pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
onclive·May 12·1 min read
save

Honesty and Humor Offer Hope in Breast Cancer Survivorship, Says Dr Nunnery and Survivor Annie Bond

May 12, 2026·read at onclive ↗Positive

The Breast Cancer Briefing podcast, hosted by Dr Sara Nunnery of Tennessee Oncology, featured a conversation with Annie Bond, a breast cancer survivor and patient advocate.

Bond, who was first diagnosed at age 26, described how early concerns about a breast lump were dismissed because of her youth and lack of family history, leading to a delayed diagnosis that allowed the disease to spread to her liver. She stressed the need for patients to persist, seek multiple opinions, and advocate for themselves.

The discussion also highlighted the emotional impact of cancer, with Bond noting the mental health challenges she faced and the importance of personalized treatment decisions, such as using CDK4/6 inhibitors instead of immediate chemotherapy for her luminal A subtype.

source

This writeup was produced by pharmadog from original reporting by onclive.

Original headline: “Honesty and Humor Provide Hope in Breast Cancer Survivorship: With Sara Nunnery, MD, MSCI; and Annie Bond”

read at onclive ↗
1,734 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING
drugs
icosapent ethyl3KEYTRUDA2KEYTRUDA QLEX2pembrolizumab2FULVESTRANTNovel Therapeuticrituximabsacituzumab govitecantrastuzumabvepdegestrant
topics
Oncology45Breast Cancer19HER26NSCLC3Psychiatry & CNS3TROP-23Antibody-Drug Conjugate (ADC)2Approval2CDK4/62Hepatology2Oncolytic Virus2Prostate Cancer2Radioligand Therapy2AMDAMLBispecific AntibodyDiabetic Macular EdemaEGFREndocrinology & MetabolismGlioblastomaHematologyImmunologyMelanomaMonoclonal AntibodyMultiple MyelomaNeurologyPI3KPainSmall Molecule

related stories

  • May 9The OncFive: Top Oncology Articles for the Week of 5/3onclive
  • May 11MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumorsonclive
  • May 12Dr McCann on the FDA Approval of Vepdegestrant for ESR1-Mutated, ER+ Advanced Breast Canceronclive
  • May 12GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026onclive
  • May 12Dr Postow on the Timing of Delayed or Re-Emergent irAEs in Melanomaonclive